What clinical trials are available for recurrent Cervical Cancer

Clinical Trials for Recurrent Cervical Cancer

I appreciate your question about clinical trial options. While I can provide educational information about how clinical trials work for recurrent cervical cancer, finding the specific trials available to you requires current, real-time information that changes frequently.

How Clinical Trials Are Used for Recurrent Cervical Cancer

According to the NCCN Guidelines for Cervical Cancer, clinical trials play an important role in treating recurrent or metastatic cervical cancer, particularly when testing newer immunotherapy and targeted therapy approaches. Here's what you should know:

Types of Trials Being Conducted

Immunotherapy Trials are a major focus:

• Trials testing checkpoint inhibitors (drugs that help your immune system fight cancer)
• Studies combining immunotherapy with chemotherapy
• Trials for patients with specific biomarkers like PD-L1 positive tumors

Targeted Therapy Trials for patients with specific genetic mutations:

• HER2-mutant cervical cancer
• RET fusion-positive cancers
• NTRK fusion-positive cancers

Combination Therapy Trials testing newer drug combinations that may improve outcomes beyond standard chemotherapy

How to Find Current Clinical Trials

The NCCN Guidelines for Patients: Cervical Cancer specifically recommends these resources:

1. ClinicalTrials.gov - The official U.S. registry where you can search by:

   • Your cancer type (cervical cancer)
   • Your disease status (recurrent/metastatic)
   • Your location
   • Specific biomarkers if you've been tested

2. NCI's Cancer Information Service (CIS) - Call 1-800-4-CANCER for personalized help finding trials that match your specific situation

3. Your Oncology Team - Your doctor can identify trials you're eligible for based on:

   • Your specific cancer characteristics
   • Your overall health
   • Your previous treatments
   • Your biomarker test results (PD-L1, HER2, etc.)

Important Questions to Ask Your Care Team

When discussing clinical trials with your oncologist:

1. "Are there any clinical trials available for my specific type of recurrent cervical cancer?" - This helps identify options tailored to your situation

2. "What biomarker testing have I had, and are there trials designed for my results?" - According to NCCN Guidelines, biomarker testing is critical for guiding trial eligibility

3. "What are the potential benefits and side effects of the trial compared to standard treatment?" - This helps you understand the risk-benefit profile

4. "What is the trial's phase, and what outcomes are being measured?" - Phase 2 and 3 trials typically have more established safety data than Phase 1

5. "What are the eligibility requirements, and do I meet them?" - Some trials have specific requirements about prior treatments or organ function

Why Clinical Trials Matter for Recurrent Cervical Cancer

According to the NCCN Guidelines, newer treatments emerging from clinical trials—including immunotherapies like pembrolizumab and cemiplimab, as well as targeted therapies—have shown meaningful improvements in survival for patients with recurrent cervical cancer. Many of these treatments were first tested in clinical trials before becoming standard options.

Next Steps

1. Visit ClinicalTrials.gov and search for "cervical cancer" + "recurrent" to see current options
2. Contact NCI's Cancer Information Service at 1-800-4-CANCER for personalized assistance
3. Bring a list of trials to your next appointment with your oncologist to discuss which ones might be appropriate for you
4. Ask about your biomarker results - these often determine which trials you're eligible for

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.